| Application no. and date | 15702917.4 (espacenet) (Federated) (European Patent Register), 20150121 | | Patent/reg. no. and date | DK/EP 3096756, 20240612 | | Publication date | 20161130 | | Priority no. and date | US 201461929941 P, 20140121, US 201461981033 P, 20140417, US 201462069155 P, 20141027 | | EP pub. no. and date |
EP 3096756 20161130 | | Effective date | | | Applicant/owner | NEUROCRINE BIOSCIENCES, INC., 12790 El Camino Real
San Diego, CA 92130-1102, US | | Applicant ref. no. | V478760DK00 | | Inventor | GRIGORIADIS, Dimitri, E., 10626 Gingerwood Cove
San Diego, California 92130, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/427 (2006.01) , A61K 31/4985 (2006.01) , A61K 31/519 (2006.01) , A61P 5/38 (2006.01) | | Title | CRF1-receptorantagonister til behandling af medfødt adrenal hyperplasi | | Int. application no. | US2015012315 | | Int. publication no. | WO2015112642 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
